The increase in price target from $21 to $30 by Goldman Sachs suggests a more optimistic valuation of Nuvei's stock, which could lead to increased investor interest and a potential short-term rise in the stock price. However, the Neutral rating indicates that the analyst believes the stock is fairly valued at its current price, which may temper the impact of the price target increase.